Browse studies

Find your next paid study

27,295 recruiting studies available now

Ex-Vivo Trial of En-bloc Transurethral Resection of Bladder Tumor (En-bloc TURBT) Specimens Using a Redesigned Surgical Resectoscope Device

Background: Bladder cancer is the sixth most common cancer in the United States. The way that doctors remove tumors in bladder surgeries may leave some cancer…

Bladder Cancer

Estimated

~$10 – $675

Actual pay is set by the research site.

National Cancer Institute (NCI)NCT04235764

Sample Collection Study to Analyze Cerebral Spinal Fluid as a Biomarker for Brain Metastasis in Metastatic Breast Cancer

Background: Breast cancer is the most common cancer among women. It can often spread to the liver, lungs, bones, or brain. Breast cancer that spreads to the b…

Breast CancerBreast CarcinomaCancer of the Breast+1 more

Estimated

~$10 – $675

Actual pay is set by the research site.

National Cancer Institute (NCI)NCT07619534

Phase 1

VALIENT: Phase 1 Clinical Trial of VorAsidenib in Combination With Lomustine In Patients With rEcurrent IDH-mutaNT Glioma Harboring IDH1 and/or IDH2 Mutations

This phase I study will evaluate the safety and tolerability of vorasidenib in combination with lomustine and determine the recommended combination dose (RCD) …

Recurrent GliomaIDH-mutant Gliomas

Estimated

~$150 – $4,500

Actual pay is set by the research site.

Megan ManticaNCT07629089

Phase 2

Subcortical OCD Neuromodulation With Acoustic Therapy - Dose Duration Optimization

This study is testing a new, non-invasive brain stimulation approach for adults with Obsessive Compulsive Disorder (OCD). Researchers are evaluating the safety…

Obsessive - Compulsive Disorder

Estimated

~$75 – $2,000

Actual pay is set by the research site.

University of PennsylvaniaNCT07887633

Phase 2

A Long-term Extension Study to Evaluate the Safety and Efficacy of APG777 in Patients With Atopic Dermatitis Previously Treated With APG777

This is a multicenter, double-blind, Long-Term Extension (LTE) study to evaluate the long-term safety and efficacy of APG777 in patients with moderate-to-sever…

Atopic Dermatitis

Estimated

~$75 – $2,800

Actual pay is set by the research site.

Apogee Therapeutics, Inc.NCT07003425

Phase 1

Phase I Open-Label Safety Trial of Pembrolizumab for Neurological Post-Acute Sequelae of SARS-CoV-2 (PD1-PASC I)

Background: SARS-CoV-2 is the virus that causes COVID-19. Some people who recover from an acute COVID-19 infection may continue to have symptoms that persist …

Post-Acute COVID-19 Syndrome

Estimated

~$150 – $2,700

Actual pay is set by the research site.

National Institute of Neurological Disorders and Stroke (NINDS)NCT07388550

Phase 1

A Phase 1 Study of ARC101 in Advanced Solid Tumors

This first-in-human study will evaluate the safety, tolerability, pharmacokinetics, and antitumor activity of ARC101 in patients with advanced cancer.

Advanced Solid Tumor

Estimated

~$150 – $4,500

Actual pay is set by the research site.

Third Arc BioNCT06672185

Observational

GF-NOURISH (Gluten Free Nutrition Optimization Through Ultra-processed Food Reduction and Improved Strategies for Health)

The investigators propose the Gluten Free Nutrition Optimization through Ultra-processed food Reduction and Improved Strategies for Health (GF-NOURISH) study t…

Celiac Disease in ChildrenNutrition Disorder, Child

Estimated

~$10 – $750

Actual pay is set by the research site.

Boston Children's HospitalNCT06356220

Phase 3

Randomized Phase III Study of Mosunetuzumab vs. Rituximab for Low Tumor Burden Follicular Lymphoma

This phase III trial compares the effectiveness of rituximab to mosunetuzumab in treating patients with follicular lymphoma with a low tumor burden. Rituximab …

Classic Follicular LymphomaFollicular Lymphoma With Unusual Cytological Features

Estimated

~$50 – $1,350

Actual pay is set by the research site.

National Cancer Institute (NCI)NCT06337318

A Comprehensive Clinical, Microbiological and Immunological Assessment of Patients With Suspected Post Treatment Lyme Disease Syndrome and Selected Control Populations

This study will determine whether patients who have been infected with the Lyme bacteria, Borrelia burgdorferi, and treated with antibiotics still have the bac…

Lyme Disease

Estimated

~$10 – $675

Actual pay is set by the research site.

National Institute of Allergy and Infectious Diseases (NIAID)NCT00001539

Phase 2

Epcoritamab as Consolidative Therapy for Waldenstrom Macroglobulinemia (WM) Treated With a Bruton Tyrosine Kinase Inhibitor (BTKi)

Background: Waldenstrom macroglobulinemia (WM) is a type of blood cancer. It causes the blood to get thicker, which slows circulation and makes it harder to c…

Waldenstrom Macroglobulinemia

Estimated

~$75 – $1,800

Actual pay is set by the research site.

National Heart, Lung, and Blood Institute (NHLBI)NCT07882173

Observational

A Post-market Multi-center Prospective Study to Assess the Ability of the Portable Scalp Cooling System (PSCS) to Prevent Hair Loss in Women Receiving Specific Chemotherapy Regimens for Breast Cancer Stages I-III.

The purpose of this prospective study is to assess the ability of AMMA to prevent hair loss in women receiving chemotherapy (CT) for early-stage breast cancer.…

AlopeciaChemotherapy-induced AlopeciaHair Loss+1 more

Estimated

~$10 – $1,050

Actual pay is set by the research site.

Cooler Heads Care Inc.NCT05484973